Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China · Delayed Price · Currency is CNY 11.29
+0.16 (1.44%)
Feb 4, 2026, 3:04 PM CST
SHE:000590 Revenue
Guhan Pharmaceutical Group had revenue of 82.38M CNY in the quarter ending September 30, 2025, with 18.40% growth. This brings the company's revenue in the last twelve months to 351.79M, up 1.60% year-over-year. In the year 2024, Guhan Pharmaceutical Group had annual revenue of 343.21M, down -15.18%.
Revenue (ttm)
351.79M
Revenue Growth
+1.60%
P/S Ratio
7.69
Revenue / Employee
303.53K
Employees
1,159
Market Cap
2.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 343.21M | -61.44M | -15.18% |
| Dec 31, 2023 | 404.65M | 54.12M | 15.44% |
| Jan 1, 2023 | 350.53M | 49.75M | 16.54% |
| Jan 1, 2022 | 300.77M | 25.68M | 9.34% |
| Dec 31, 2020 | 275.09M | -39.94M | -12.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 4.15B |
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Chengdu huasun technology group Inc. , LTD. | 658.28M |
| Ginwa Enterprise (Group) | 550.44M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |